ciprofloxacin - CISMeF

Preferred Label : ciprofloxacin;

MeSH definition : A broad-spectrum antimicrobial carboxyfluoroquinoline.;

MeSH hyponym : ciprofloxacin hydrochloride anhydrous; cipro; Bay-09867; Ciprofloxacin Hydrochloride; ciprinol; Anhydrous, Ciprofloxacin Hydrochloride; Hydrochloride Anhydrous, Ciprofloxacin; Hydrochloride, Ciprofloxacin; Ciprofloxacin Monohydrochloride Monohydrate; Monohydrate, Ciprofloxacin Monohydrochloride; Monohydrochloride Monohydrate, Ciprofloxacin; Bay 09867; Bay09867;

MeSH CAS label : 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-;

MeSH Related Number : ciprofloxacin hydrochloride; 86393-32-0 (Ciprofloxacin hydrochloride); ciprofloxacin hydrochloride anhydrous; 85721-33-1 (Ciprofloxacin); 0MP32MFP6C; 4BA73M5E37;

Registry Number MeSH : 85721-33-1;

Related CAS MeSH : 0MP32MFP6C (Ciprofloxacin hydrochloride anhydrous); 4BA73M5E37 (Ciprofloxacin hydrochloride);

Wikipedia link : https://en.wikipedia.org/wiki/Ciprofloxacin;

Is substance : O;

UNII : 5E8K9I0O4U;

InChIKey : MYSWGUAQZAJSOK-UHFFFAOYSA-N;

Details

Origin ID

D002939;

UMLS CUI

C0008809;

ATC code(s)
- ciprofloxacin [ATC Code]
ATC code(s)
- ciprofloxacin [ATC Code]
- ciprofloxacin [ATC Code]
- ciprofloxacin [ATC Code]
- ciprofloxacin [ATC Code]
- ciprofloxacin and metronidazole [ATC Code]
- ciprofloxacin and ornidazole [ATC Code]
- ciprofloxacin and tinidazole [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Ciprofloxacin adverse reaction (disorder) [SNOMED CT concept]
- Ciprofloxacin measurement (procedure) [SNOMED CT concept]
- ciprofloxacin [Substance BNPC]
Currated CISMeF NLP mapping
- Ciprofloxacin [ICD-11 Extension code]
- Ciprofloxacin [LOINC component]
- Ciprofloxacin [ICHI extension code]
- Ciprofloxacin [NCIt concept]
- Ciprofloxacin (substance) [SNOMED CT concept]
- Product containing ciprofloxacin in ocular dose form (medicinal product form) [SNOMED CT concept]
- ciprofloxacin [SNOMED Notion]
Pharmacological action(s)
- Cytochrome P-450 CYP1A2 Inhibitors [MeSH Descriptor]
- anti-bacterial agents [MeSH Descriptor]
- antineoplastic agents [MeSH Descriptor]
- topoisomerase II inhibitors [MeSH Descriptor]
Record concept(s)
- Bay-09867 [MeSH concept]
- Ciprofloxacin Hydrochloride [MeSH concept]
- ciprinol [MeSH concept]
- cipro [MeSH concept]
- ciprofloxacin [MeSH concept]
- ciprofloxacin hydrochloride anhydrous [MeSH concept]
Related MeSH Supplementary Concept(s)
- (ciprofloxacin)2(Bi2Cl10) [MeSH Supplementary Concept]
- 1-cyclopropyl-6-fluoro-3-formyl-1,4-dihydro-4-oxo-7-piperazinylquinoline [MeSH Supplementary Concept]
- 3,4-dimethylciprofloxacin [MeSH Supplementary Concept]
- 3Mix ointment [MeSH Supplementary Concept]
- 6-fluoro-7-(1-piperazinyl)-1-(2'-phenyl-1'-cyclopropyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid [MeSH Supplementary Concept]
- 7-(2-aminoethoxy)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid [MeSH Supplementary Concept]
- 7-(2-aminoethylthio)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid [MeSH Supplementary Concept]
- 7-(2-aminomethylmorpholino)-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid [MeSH Supplementary Concept]
- 8-fluorociprofloxacin [MeSH Supplementary Concept]
- 99mTc-CPFXDTC [MeSH Supplementary Concept]
- CNV9710 [MeSH Supplementary Concept]
- FD 501 [MeSH Supplementary Concept]
- HMNE3 compound [MeSH Supplementary Concept]
- N-(2-(4-fluorophenyl)-2-oxoethyl)ciprofloxacin [MeSH Supplementary Concept]
- N-(2-phenyl-2-oxoethyl)ciprofloxacin [MeSH Supplementary Concept]
- N-desmethylamifloxacin [MeSH Supplementary Concept]
- PD 135042 [MeSH Supplementary Concept]
- PD 160793 [MeSH Supplementary Concept]
- PD 161148 [MeSH Supplementary Concept]
- SYN 987 [MeSH Supplementary Concept]
- SYN-1193 [MeSH Supplementary Concept]
- SYN-1253 [MeSH Supplementary Concept]
- TreVitaMix [MeSH Supplementary Concept]
- UB 8902 [MeSH Supplementary Concept]
- WM5 compound [MeSH Supplementary Concept]
- amifloxacin [MeSH Supplementary Concept]
- amifloxacin N-oxide [MeSH Supplementary Concept]
- betacyclodextrin, ciprofloxacin drug combination [MeSH Supplementary Concept]
- bismuth(III)-ciprofloxacin 1 [MeSH Supplementary Concept]
- cifran [MeSH Supplementary Concept]
- ciprofloxacin dithiocarbamate [MeSH Supplementary Concept]
- ciprofloxacin, hydrocortisone drug combination [MeSH Supplementary Concept]
- ciprofloxacin-7-ethylenediamine [MeSH Supplementary Concept]
- difloxacin [MeSH Supplementary Concept]
- orbifloxacin [MeSH Supplementary Concept]
- oxociprofloxacin [MeSH Supplementary Concept]
- piperazinyl-cross-linked ciprofloxacin dimer [MeSH Supplementary Concept]
- pirfloxacin [MeSH Supplementary Concept]
- poly(1,6-hexanediisocyanate-co-polycaprolactonediol-co-ciprofloxacin) [MeSH Supplementary Concept]
- ro 24-4383 [MeSH Supplementary Concept]
- ro 24-6392 [MeSH Supplementary Concept]
- ro 24-6778 [MeSH Supplementary Concept]
- ro 25-0534 [MeSH Supplementary Concept]
- sarafloxacin [MeSH Supplementary Concept]
- sulfociprofloxacin [MeSH Supplementary Concept]
- technetium tc 99m ciprofloxacin [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Ciprofloxacin [LOINC component]
- Ciprofloxacin [ICD-11 Extension code]
- Ciprofloxacin [NCIt concept]
- Ciprofloxacin (substance) [SNOMED CT concept]
- Product containing ciprofloxacin (medicinal product) [SNOMED CT concept]
- ciprofloxacin [ATC Code]
- ciprofloxacin [ATC Code]
- ciprofloxacin [ATC Code]
- ciprofloxacin [ATC Code]
- ciprofloxacin [Substance BNPC]
- ciprofloxacin [SNOMED Notion]
Validated automatic mappings to BTNT
- Ciprofloxacin Hydrochloride [NCIt concept]
- ciprofloxacin [ATC Code]
- ciprofloxacin [ATC Code]
- ciprofloxacin [ATC Code]
- ciprofloxacin [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients